Meet Massachusetts’s 101 Top Founders in the Medical Space

Robert Langer

Co-Founder of 480 Biomedical

Robert Langer is the David H.Koch Institute Professor at the Massachusetts Institute of Technology (MIT) (being an Institute Professor is the highest honor that can be awarded to a faculty member). Robert has written over 1,100 articles. Robert also has approximately 760 issued and pending patents worldwide.Robert’s patents have been licensed or sublicensed to over 220 pharmaceutical, chemical, biotechnology and medical device companies. Robert served as a Member of the United States Food and Drug Administration’s SCIENCE Board, the FDA’s highest Advisory Board, from 1995 to 2002 and as its Chairman of the Board of Directors from 1999 to 2002. Robert has received over 180 major awards, including the 2006 United States National Medal of Science; the Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers; and the 2008 Millennium Prize, the world’s most prestigious technology prize. Robert is also the only engineer to receive the Gairdner Foundation International Award; 72 recipients of this award have subsequently received a Nobel Prize. Among numerous other awards Robert has received are the Dickson Prize for Science (2002); the Heinz Award for Technology, Economy and Employment (2003); the Harvey Prize (2003); the John Fritz Award (2003) (given previously to inventors such as Thomas Edison and Orville Wright); the General Motors Kettering Prize for Cancer Research (2004); the Dan David Prize in Materials Science (2005); the Albany Medical Center Prize in Medicine and Biomedical Research (2005), the largest prize in the U.S. for medical research; induction into the National Inventors Hall of Fame (2006); the Max Planck Research Award (2008); and the Prince of Asturias Award for Technical and Scientific Research (2008). In 1998, Robert received the Lemelson-MIT prize, the world’s largest prize for invention for being “one of history’s most prolific inventors in medicine.” In 1989 Robert was elected to the Institute of Medicine of the National Academy of Sciences and in 1992 he was elected to both the National Academy of Engineering and the National Academy of Sciences. Robert is one of very few people ever elected to all three United States National Academies and the youngest in history (at age 43) to ever receive this distinction. Forbes magazine (1999) and Bio World (1990) have named Robert as one of the 25 most important individuals in biotechnology in the world. Discover magazine (2002) named him as one of the 20 most important people in this area. Forbes magazine (2002) selected Robert as one of the 15 innovators worldwide who will reinvent our future. Time magazine and CNN (2001) named Robert as one of the 100 most important people in America and one of the 18 top people in science or medicine in America (America’s Best). Parade magazine (2004) selected Robert as one of six “Heroes whose research may save your life.” Robert has received honorary doctorates from Harvard University, the Mt. Sinai School of Medicine, Yale University, the ETH (Switzerland), the Technion (Israel), the Hebrew University of Jerusalem (Israel), the Universite Catholique de Louvain (Belgium), Rensselaer Polytechnic Institute, Willamette University, the University of Liverpool (England), the University of Nottingham (England), Albany Medical College, Pennsylvania State University, Northwestern University, and Uppsala University (Sweden), and he received the University of California–San Francisco Medal. Robert urrently serves as a Member of the Board of Directors of Advanced Cell Technology and previously served as a Member of the Board of Directors at Momenta Pharmaceuticals from 2001 to 2009, Wyeth from 2004 to 2009, Fibrocell Science, Inc. from 2010 to 2012 and Millipore Corp from 2009 to 2010. Robert received his Bachelor’s Degree from Cornell University in 1970 and his ScD from the Massachusetts Institute of Technology in 1974, both in chemical engineering.

Follow Robert Langer:

• Crunchbase
• Linkedin

About 3D-Matrix Medical Inc., 480 Biomedical, Arsenal Medical, Arsia Therapeutics, BIND Therapeutics, Entrega Bio, Kala Pharmaceuticals, Living Proof, LyfeBulb, Lyra Therapeutics, Massachusetts Institute of Technology, Moderna Therapeutics, PixarBio, Seer, Suono Bio, Teal Bio, TISSIUM, Verseau Therapeutics: 480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery.

• Website
• Crunchbase
• Linkedin